_____. 2002. Antidepressants for the Heart. Harvard Mental Health Letter., 18:9.
_____. 2002. Disaster and Trauma. Harvard Mental Health Letter. 18:7.
Agency for Healthcare Research and Quality. 2002. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Summary Report, AHRQ Publication No. 02-E033. Rockville, MD: Agency for Healthcare Research and Quality, ahrq.gov.
Ainsworth, P. 2000. Understanding Depression. Jackson, MS: University Press of Mississippi.
Akiskal, H. S. 1996. The prevalent clinical spectrum of bipolar disorders: beyond DSMIV. Journal of Clinical Psychopharmacology,. 16:(suppl)4s-14s.
American Academy of Neurology. 2008. Does Gingko Biloba Affect Memory? sciencedaily.com.
American Psychiatric Association, The DSM IV, American Psychiatric Association, 1994.
Anderson, P. 2008. Low Testosterone Levels Linked with Higher Risk of Depression. Medscape Medical News, medscape.com.
Appleton, W. 2000. Prozac and the New Antidepressants. New York: Penguin Putnam, Inc.
Arato, M., C.M. Banki, G. Bissette, C.B. Nemeroff. 1989. Elevated CSF CRF in suicide victims. Biological Psychiatry 25(3):355-359.
Arnstein, Amy F.T. 2007. Alpha-2 agonists in the treatment of ADHD. Medscape Psychiatry & Mental Health, medscape.com.
Beaubrun, G., and G. E. Gary. 2000. A review of herbal medicines for psychiatric disorders. Psychiatric Services 51(9):1130-1134.
Bender, K. J., ed. 1993. Narcotic agents for alcoholism. Psychotropics. 13:6-8.
Benet, L. Z., J. R. Mitchell, and L. B. Sherner. 1990a. General Principles. In Goodman &Gilman’s: The Pharmacological Basis of Therapeutics. A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor, eds. New York: Pergamon Press.
Bentley, K., and Walsh, J. 2001. The Social Worker and Pyschotropic Medication. 2nd Edition. New York: The Free Press.
Brown, S. A. and M. A. Schuckit. 1988. Changes in depression among abstinent alcoholics. Journal of the Study of Alcoholism. 49:412-417.
Charney, D.S., Nemeroff, C.B., Braun, S. 2004. The Peace of Mind Prescription: An Authoritative Guide to Finding the Most Effective Treatment for Anxiety and Depression. Boston: Houghton Mifflin.
Cowley, G., et al. 1990. A breakthrough drug for depression. Newsweek, March 26.
Davis, J. M. et al. A meta-analysis of the efficacy of second generation antipsychotics. Archives of General Psychiatry 2003. June; 60:553-64.
Diamond, R. 2002. Instant Psychopharmacology. 2nd Edition. New York: W. W. Norton and Company.
Dubovsky, s. 2003. Fluoxetine safety during pregnancy and lactation. Journal Watch Psychiatry. 9:7.
Einarson, A. 2005. The safety of psychotropic drug use during pregnancy: a review. Medscape General Medicine. 7(4), medscape.com.
Empfield, M., Bakalar, N. 2001. Understanding Teenage Depression: A Guide to Diagnosis, Treatment, and Management. New York: H. Holt.
Fowler, M. 2001. Maybe You Know My Teen: A Parent’s Guide to Helping Your Adolescent with Attention Deficit Hyperactivity Disorder. New York: Broadway Books.
Geller, B. 2003. Serotonergic symptoms in SSRI exposed infants. Journal Watch Psychiatry. 9:10.
Geller, B. Antidepressants during pregnancy: benefits for children. Journal Watch Psychiatry. 9:1.
Ghaemi, S. N. 2000. New treatments for bipolar disorder: the role of atypical neuroleptic agents. Journal of Clinical Psychopharmacology. 61: (suppl)33-42.
Gitlin, M. 1996. Neurology/Psychiatry Update. Pharmacist’s Letter. 18:3.
Gitlin, M.J. 1996. The Psychotherapist’s Guide to Psychopharmacology. 2nd Edition. New York: Free Press.
Glazener, F. S. 1992. Adverse drug reactions. In Melmon and Morrelli’s Clinical Pharmacology: Basic Principles in Theraputics. 3rd Edition. D. W. Nierenberg, ed. New York: McGraw-Hill.
Harvard Medical School. 2008. A SAD Story: Seasonal Affective Disorder. Harvard Health Letter.
Harvard University. 2003. Study Suggests Depressed Men May Benefit from Testosterone Replacement Therapy. hms.Harvard.edu/news/
Helgoe, L.A., Wilhelm, L.R., Kommor, M.J. 2005. The Anxiety Answer Book. Naperville, IL: Sourcebooks.
Hoffman, R.E., et al. 2000. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 355:1073-1075.
Jellin, J. 2002. Neurology/Psychiatry Update. Pharmacists Letter. 18:10.
Jellin, J. 2002. Pediatrics Update. Pharmacists Letter. 18:8.
Jellin, J. 2002. Psychotropic Medication Update. The Brown University Child and Adolescent Psychopharmacology Update. 4:10, 5:2.
Johnson, B. A. et al. 2003. Oral topiramate for treatment of alcohol dependence. Lancet. May 17; 261:1677-85
Kraepelin, E. 1921. Textbook of Psychiatry, 7th Edition. (abstracted). Translated by Diefendorf. London: MacMillan 1907.
Kramer, P.D. 1997. Listening to Prozac: The Landmark Book About Antidepressant and the Remaking of the Self. Revised Edition. New York: Penguin.
LaPlante, B.J. 2007. Atypical antipsychotics and bipolar disorder. Medscape Psychiatry & Mental Health, medscape.com.
Manos, M. J. 2005. Opinions on drug holidays in pediatric ADHD. Medscape Psychiatry & Mental Health. 10(2), medscape.com.
Martin, A., Scahill, L., Charney, D., and Leckman, J. 2003. Pediatric Psychopharmacology, Principles and Practice. New York, NY: Oxford University Press, Inc.
Mayo Foundation for Medical Education and Research. 2006. Electroconvulsive Therapy (ECT): Treating Severe Depression and Mental Illness, mayoclinic.com.
Miller, R., Mason, S.E., eds. 2002. Diagnosis: Schizophrenia: A Comprehensive Resource for Patients, Families, and Helping Professionals. New York: Columbia University Press.
Mischoulon, D., et al. 1999. Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice. Harvard Review of Psychiatry. 6:322-326.
National Institute of Mental Health, National Institutes of Health. 2007. Meeting Summary: Childhood and Adolescent Onset Schizophrenia: Research Challenges and Opportunities, nimh.nih.gov.
Neziroglu, F., Yaryura-Tobias, J.A. 1997. Over and Over Again: Understanding Obsessive-Compulsive Disorder. San Francisco: Jossey-Bass.
Nidhino, S. E., E. Mignot, and W. C. Dement. 1998. Sedative-hypnotics. In Textbook of Psychopharmacology. 2nd Edition. A. F. Schatzberg and C. B. Nemeroff, eds. 487-502.
Osborn, I. 1998. Tormenting Thoughts and Secret Rituals: The Hidden Epidemic of Obsessive-Compulsive Disorder. New York: Pantheon Books.
Page, D. 2006. UCLA Develops Unique Nerve-stimulation Epilepsy Treatment, http://newsroom.ucla.edu.
Papolos, D., Papolos, J. 1999. The Bipolar Child. New York: Broadway Books.
PDR staff/editors. 2008. Physicians’ Desk Reference. New York: Thomson Healthcare.
Peet, M., D.F. Horribin. 2002 A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59:913-919.
Perry, P. el al. 2002.Testosterone therapy in late-life major depression in males. Journal of Clinical Psychiatry. Dec. 63:12 1096-1101.
Pollock, V. E. 1992. Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics. American Journal of Psychiatry. 149:1534-1538.
Porter, R. 2002. Madness: A Brief History. Oxford, NY: Oxford University Press.
Preston, J., O’Neal, M., and Talaga, M. 2002. Handbook of Clinical Psychopharmacology for Therapists. 3rd Edition. Oakland, CA: New Harbinger.
Rosen, L.E., Amador, X.F. 1996. When Someone You Love is Depressed: How to Help Your Loved One without Losing Yourself. New York: Free Press.
Roy-Byrne, P. 2003. Antidepressant effects of SAMe, Redux. Journal Watch Psychiatry. 9:1.
Roy-Byrne, P. 2003. The new ADHD drug atomoxetine: its mechanism for action. Journal Watch Psychiatry. 9:1.
Scherk, H., F.G. Pajonk, S. Leucht. 2007. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Archives of General Psychiatry. 64(4):442-455.
Schildkraut, J. J. 1970. Neuropsychopharmacology and the Affective Disorders (New England Journal of Medicine Medical Progress Series). New York: Little, Brown.
Stahl, S. 1999. Psychopharmacology of Antipsychotics. London: Martin Dunitz.
Surman, C.B.H., R. Weisler. 2006. The state of the art treatment for pediatric and adolescent ADHD, medscape.com.
Terr, L. C. 1991. Childhood traumas: an outline and overview. American Journal of Psychiatry. 148:10-20.
Thase, M.E., R.H. Howland. 1995. Biological processes in depression: an updated review and integration. In Handbook of Depression. E. E. Beckham and W. R. Leber, eds. New York: Guilford Press.
Torrey, E.F. 2001. Surviving Schizophrenia: A Manual for Families, Consumers, andProviders. 4th Edition. New York: Quill.
Tucker, G. 2003 Antidepressants still don’t seem to make a difference in bipolar depression. Journal Watch Psychiatry. 9:2.
Tucker, G. 2003. SSRIs during pregnancy: another view. Journal Watch Psychiatry. 9:7. U.S. Food and Drug Administration. Antidepressant Use in Children, Adolescents, and Adults, fda.gov.
Wegmann, J. 2008. Psychopharmacology: Straight Talk on Mental Health Medications.Eau Claire, WI: Pesi, LLC.
White, R.F. 2006. Pharmacologic advances in the treatment of ADHD in adults: an expertinterview with Richard H. Weisler, MD. Medscape Psychiatry & Mental Health 11(1), medscape.com.
White, R.F. 2006. Quality of life and treatment outcomes with once-daily medications for ADHD: an expert interview with Joseph Biederman, MD. Medscape Psychiatry &Mental Health. 11(1), medscape.com.
Wooten, J., J. Galavis. 2005. Polypharmacy: Keeping the Elderly Safe, rnweb.com.
Zetin, M., and Tate, D. 1999. The Psychopharmacology Sourcebook.Lincolnwood, IL: Lowell House.
Agency for Healthcare Research & Quality, ahrq.gov
American Academy of Child and Adolescent Psychiatry, aacap.org
American Psychiatric Association, psych.org
National Council on Patient Information and Education, talkaboutrx.org
National Institute of Mental Health, National Institutes of Health, nimh.nih.gov
National Mental Health Information Center, Substance Abuse and Mental Health
Services (SAMHSA), U.S. Department of Health and Human Services, mentalhealth.samhsa.gov
U.S. Food and Drug Administration, fda.gov
World Health Organization, who.int